Quick summary: Importation of US-Authorized Methotrexate for Injection, USP Due to the Current Shortage of Canadian-Authorized Methotrexate Injection BP, 25 mg/mL . Date: 2024-10-23.
Public recall detail
Importation of US-Authorized Methotrexate for Injection, USP Due to the Current Shortage of Canadian-Authorized Methotrexate Injection BP, 25 mg/mL
2024-10-23
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: Importation of US-Authorized Methotrexate for Injection, USP Due to the Current Shortage of Canadian-Authorized Methotrexate Injection BP, 25 mg/mL . Date: 2024-10-23.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandMethotrexate for Injection, USP
ProductUS-Authorized Methotrexate for Injection, USP
IssueHealth products - Supply Health products - Dosage Health products - Packaging
IdentificationRA-76376
Affected products
BrandMethotrexate for Injection, USP
ProductMethotrexate for Injection, USP
DIN / NPN / authorizationUnited States of America NDC: 63323-122-50
Dosage formVial of lyophilized powder containing methotrexate sodium equivalent to 1 g methotrexate Concentration of 50 mg/mL, after reconstitution
StrengthVial of lyophilized powder containing methotrexate sodium equivalent to 1 g methotrexate Concentration of 50 mg/mL, after reconstitution
CodesUnited States of America NDC: 63323-122-50
Issue
What you should do
- See Key Messages below
Additional official information
AudienceHealth professionals
CategoryHealth products - Drugs
CompaniesPublished by Health Canada
DistributionNational
Published byHealth Canada
Alert / recall typeHealth professional risk communication
Identification numberRA-76376
Background{}
CompaniesPublished by Health Canada
AudiencesHealth professionals
Source updated2024-10-23
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.